BusinessWire BiotechOriginal article
Werner® Reports Preliminary Third Quarter 2026 Financial Results
EarningsNeutral
AI Analysis
Summary
Werner Enterprises, a transportation and logistics provider (not a biotech/pharma company), reported preliminary Q3 2026 results with revenue of about $946-$951 million and GAAP diluted EPS of $0.10-$0.11. Non-GAAP adjusted diluted EPS is expected at $0.15-$0.16.
Financial Highlights
Revenue
$946 million to $951 million (preliminary Q3 2026)
EPS
GAAP diluted $0.10-$0.11; non-GAAP adjusted diluted $0.15-$0.16
Outcome Details
Preliminary unaudited Q3 2026 results: total revenues ~$946M-$951M; GAAP diluted EPS ~$0.10-$0.11; non-GAAP adjusted diluted EPS ~$0.15-$0.16
Importance:2/10
Sentiment:
0.00
earningspreliminary resultstransportationlogisticsnon-biotech
Related Companies
Read the original article
Published by BusinessWire Biotech on October 19, 2026 1:00 PM
